Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Ann Otol Rhinol Laryngol. 2015 May 29;124(11):864–874. doi: 10.1177/0003489415589363

Table 3.

Group-based values (mean ± SD) for voice use summary statistics of sound pressure level (SPL), fundamental frequency (f0), and vocal dose measures for weeklong data collected from the patient and matched-control groups (n = 35 pairs). The first row reports the duration of monitoring during the week in hours/minutes/seconds (hh:mm:ss). Test statistics exhibiting statistically significant differences between patient-control pairs are labeled with an asterisk (*, p < 0.003). Paired t-test statistics are derived from the pairwise comparison of each summary statistic for control values minus their matched patient values.

Voice use summary statistic Patient group Paired control group Paired t-test statistic KS test statistic
Monitored duration (hh:mm:ss) 80:24:31 ± 14:49:48 81:32:21 ± 11:36:35 0.37 0.14
SPL (dB SPL re 15 cm)
 Mean 84.4 ± 4.5 83.6 ± 4.8 −0.91 0.11
 Standard deviation 12.1 ± 2.0 12.9 ± 2.2 1.63 0.23
 Minimum 63.4 ± 5.5 61.6 ± 5.8 −1.40 0.23
 Maximum 103.6 ± 6.9 104.6 ± 6.7 0.75 0.17
 Range 40.2 ± 7.3 43.0 ± 7.9 1.55 0.23
f0 (Hz)
 Mode 198.1 ± 22.6 202.9 ± 18.1 1.15 0.20
 Standard deviation 76.1 ± 17.6 88.0 ± 18.9 3.48* 0.31
 Minimum 167.5 ± 17.4 170.9 ± 14.2 1.10 0.23
 Maximum 396.2 ± 67.1 437.2 ± 61.8 3.49* 0.34
 Range 228.6 ± 57.9 266.3 ± 59.8 3.45* 0.31
Phonation time
 Cumulative (hh:mm:ss) 08:01:02 ± 02:14:43 07:33:39 ± 02:32:51 −0.87 0.23
 Normalized (%) 10.0 ± 2.3 9.3 ± 2.7 −1.37 0.20
Cycle dose
 Cumulative (millions of cycles) 7.208 ± 2.278 7.324 ± 2.851 0.22 0.17
 Normalized (cycles/hr) 89,624 ± 23,879 89,759 ± 30,384 0.02 0.14
Distance dose
 Cumulative (m) 27,701 ± 9,303 27,519 ± 12,259 −0.09 0.14
 Normalized (m/hr) 345.3 ± 98.1 337.0 ± 134.5 −0.37 0.17